Home › Research › Health systems and care delivery
Evaluating The Accuracy Of Medicare Risk Adjustment For Alzheimer’s Disease And Related Dementias
Natalia Festa, Mary Price, Max L. Weiss, Lidia M.V.R. Moura, Nicole M. Benson, Sahar F. Zafar, Deborah Blacker, Sharon‐Lise T. Normand et al.. Health Affairs, 2022-09-01
Topic: Risk, prevention and care in population studies
Plain-language summary
In 2020 Medicare reintroduced Alzheimer's disease and related dementias (ADRD) Hierarchical Condition Categories (HCCs) to risk-adjust Medicare Advantage and accountable care organization (ACO) payments. The potential for Medicare spending increases from this policy change are not well understood because the baseline accuracy of ADRD HCCs is uncertain. Using linked 2016-18 claims and electronic health record data from a large ACO, we evaluated the accuracy of claims-based ADRD HCCs against a reference standard of clinician-adjudicated disease. An estimated 7.5 percent of beneficiaries had clinician-adjudicated ADRD. Among those with ADRD HCCs, 34 percent did not have clinician-adjudicated disease. The false-negative and false-positive rates were 22.7 percent and 3.2 percent, respectively. Medicare spending for those with false-negative ADRD HCCs exceeded that of true positives by $14,619 per beneficiary. If, after the reintroduction of risk adjustment for ADRD, all false negatives were coded as having ADRD, expenditure benchmarks for beneficiaries with ADRD would increase by 9 percent. Monitoring ADRD coding could become challenging in the setting of concurrent incentives to decrease false-negative rates and increase false-positive rates.
What this study adds
Evidence grade: Low
Since 2020, Medicare has paid Medicare Advantage plans and accountable care organizations more for patients coded with dementia, yet how accurate those codes were was not well understood. Using 2016-18 records from one large accountable care organization, this study found that 34 percent of people with a dementia billing code did not have dementia on clinician review, while 22.7 percent of people who did have dementia were not coded.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Festa, N., Price, M., Weiss, M. L., Moura, L. M., Benson, N. M., Zafar, S. F., et al. (2022). Evaluating The Accuracy Of Medicare Risk Adjustment For Alzheimer’s Disease And Related Dementias. Health Affairs. https://doi.org/10.1377/hlthaff.2022.00185
Vancouver
Festa N, Price M, Weiss ML, Moura LM, Benson NM, Zafar SF, et al. Evaluating The Accuracy Of Medicare Risk Adjustment For Alzheimer’s Disease And Related Dementias. Health Affairs. 2022. doi:10.1377/hlthaff.2022.00185. PMID: 36067434.
BibTeX
@article{festa2022-36067434,
author = {Festa, Natalia and Price, Mary and Weiss, Max L. and Moura, Lidia M.V.R. and Benson, Nicole M. and Zafar, Sahar F. and Blacker, Deborah and Normand, Sharon‐Lise T. and others},
title = {{Evaluating The Accuracy Of Medicare Risk Adjustment For Alzheimer’s Disease And Related Dementias}},
journal = {Health Affairs},
year = {2022},
doi = {10.1377/hlthaff.2022.00185},
pmid = {36067434},
url = {https://doi.org/10.1377/hlthaff.2022.00185}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Among those with ADRD HCCs, 34 percent did not have clinician-adjudicated disease.
- The false-negative and false-positive rates were 22.7 percent and 3.2 percent, respectively.
- Medicare spending for those with false-negative ADRD HCCs exceeded that of true positives by $14,619 per beneficiary.
- If, after the reintroduction of risk adjustment for ADRD, all false negatives were coded as having ADRD, expenditure benchmarks for beneficiaries with ADRD would increase by 9 percent.
- Monitoring ADRD coding could become challenging in the setting of concurrent incentives to decrease false-negative rates and increase false-positive rates.
Why it matters
Since 2020, Medicare has paid Medicare Advantage plans and accountable care organizations more for patients coded with dementia, yet how accurate those codes were was not well understood. Using 2016-18 records from one large accountable care organization, this study found that 34 percent of people with a dementia billing code did not have dementia on clinician review, while 22.7 percent of people who did have dementia were not coded. The authors estimate that coding all the missed cases would raise Medicare spending benchmarks for dementia by 9 percent, and warn that payment incentives could make dementia coding harder to monitor.
Study details
- Evidence strengthLow
How this study scored 45/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Health Affairs) |
| Journal's citation record | 3 / 4 | Health Affairs: journal h-index 277 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 18 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.0 citations a year over 6 year(s) since 2022 |
| Impact for its field and year | 2 / 6 | Cited 2.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 7 other studies in this library |
| Still being cited | 1 / 4 | Cited 12 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author John Hsu: h-index 45 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 36067434) |
| Free to read | 2 / 2 | Free to read |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
7 studies in the alzhub library list this one in their references.
Related studies in Health systems and care delivery from nearby years
Also in Health systems and care delivery
172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.